Events

In this webinar, the following aspects will be presented: Discovery and early development of “non-traditional” antibacterial approaches is a noticeable trend in the pre-clinical global pipeline These approaches include anti-virulence strategies, microbiome-modifying therapies, phages and others such as nanoparticles, immunotherapy and drug-resistance modulation Some of these approaches require novel preclinical efficacy models to predict clinical […]

In this webinar, Alexander J. Lepak will review critical study elements that lead to robust preclinical PK/PD results in the murine model. Topics discussed will include: Understanding and embracing the inherent variability in many components of the murine model Demonstrating how to generate and interpret preclinical murine model PK/PD results The presentation will be followed […]